Valeant Pharmaceuticals International (VRX) announced a public offering of its common shares to raise gross proceeds of approximately $1.75 billion after the close Monday. The stock is now down 0.82 on 16K shares.
Valeant Pharmaceuticals traded in a range for the majority of Monday's session and closed up by 0.62 at $84.82. The stock has been moving in a narrow range for the last 2 weeks.
For comments and feedback: editorial@rttnews.com